StockData

Dow vs Eastman Chemical

DOW and EMN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DOW and EMN compare

Dow is the larger company, worth 3.3 times as much as Eastman Chemical ($25.1B against $7.6B).

Eastman Chemical grew revenue faster over the last twelve months (0.27% versus −1.2% for Dow).

Both pay dividends: Dow yields 4.0% and Eastman Chemical 5.1%.

Eastman Chemical scores higher on the StockData Score (16 against 6 for Dow), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDOWEMN
Size and price
Market cap$25.1B$7.6B
Share price$34.70$66.53
Change, 1 year39.6%8.9%
Change, 5 years−40.5%−40.5%
Beta (5Y)0.701.10
Employees35K13K
StockData Score
Total score616 (better)
Valuation score05 (better)
Growth score11
Performance score02 (better)
Health score3 (better)2
Dividend score26 (better)
Valuation
P/E–12.2×
P/S0.6× (better)0.8×
P/B1.6×1.2× (better)
EV/EBITDA15.3×–
P/FCF–16.2×
FCF yield–6.2%
Fair value$27.77$87.53
Margin of safety−25.0%24.0% (better)
Growth
Revenue growth (TTM)−1.2%0.27% (better)
Revenue growth, 5Y average0.73% (better)0.65%
Net income growth (TTM)–−13.3%
EPS growth (TTM)–−12.3%
EPS growth, 5Y average–3.2%
Profitability
Gross margin9.9%20.6% (better)
Net margin–6.9%
FCF margin–5.2%
Return on equity–10.4%
Financial health
Debt / equity1.130.83 (better)
Net debt / EBITDA5.26–
Current ratio1.75 (better)1.57
Altman Z-score1.562.15 (better)
Piotroski F-score–5
Dividends and buybacks
Dividend yield4.0%5.1% (better)
Payout ratio–61.1%
Years of dividend growth016 (better)
Dividend growth, 5Y average0.00%4.5% (better)
Shareholder yield4.0%5.1% (better)
Ownership
Held by institutions78.1%94.1%
Held by insiders0.28%0.83%
Insider net buying, 12 months–−$366K
Superinvestors holding–1
Short interest, % of float4.7%5.9%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.